Sign in

CIK 0001832038

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Invivyd, Inc.

Sign in to watch
Ticker
IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851403134
Phone
+1 781-819-0080
Business address
205 CHURCH STREET, NEW HAVEN, CT
Former names
Adagio Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-18 Duke William E. Chief Financial Officer Sale 10b5-1 −18,425 $0.84 $16K 168,937
2026-08-17 Duke William E. Chief Financial Officer Sale 10b5-1 −22,355 $0.72 $16K 187,362
2026-08-15 Duke William E. Chief Financial Officer Exercise or conversion 10b5-1 +102,000 209,717
2026-08-15 Duke William E. Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −102,000 0
2026-02-18 Duke William E. Chief Financial Officer Sale 10b5-1 −20,964 $1.58 $33K 107,717
2026-02-17 Duke William E. Chief Financial Officer Sale 10b5-1 −19,663 $1.54 $30K 128,681
2026-02-15 Duke William E. Chief Financial Officer Exercise or conversion 10b5-1 +99,000 148,344
2026-02-15 Duke William E. Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −99,000 102,000
2026-01-29 Duke William E. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +625,000 625,000
2025-08-19 Duke William E. Chief Financial Officer Sale 10b5-1 −29,643 $0.57 $17K 49,344
2025-08-18 Duke William E. Chief Financial Officer Sale 10b5-1 −20,013 $0.65 $13K 78,987
2025-08-15 Duke William E. Chief Financial Officer Exercise or conversion 10b5-1 +99,000 99,000
2025-08-15 Duke William E. Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −99,000 201,000
2025-02-15 Duke William E. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +950,000 950,000
2025-02-15 Duke William E. Chief Financial Officer Grant or award · Restricted Stock Units +300,000 300,000
2023-12-18 Duke William E. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-09-01 Duke William E. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +750,000 750,000

Page 1 of 1 · 17 trades